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Background
Complex chronic pain conditions, including temporoman-
dibular disorder (TMD), vestibulodynia (VBD), irritable
bowel syndrome (IBS), and widespread bodily pain (WBP),
represent a significant healthcare problem. Current treat-
ment regimens remain ineffective due to the conditions’
unclear etiology and heterogeneous clinical manifestation.
An emerging literature suggests that localized pain condi-
tions occurring in isolation result from local increases in
peripheral afferent activity, while those occurring in con-
cert result from central dysregulations in pain processing.
To understand the nature of these complex conditions
and improve standards of care, the identification of unique
biological signatures and pathways that map onto distin-
guishing clinical features is required. Thus, the objective of
this session is to discuss the relationship between pain,
related psychological characteristics, cytokine levels, and
microRNA expression profiles in individuals with localized
versus co-occurring chronic pain conditions.
Materials and methods
Two independent case-control studies were conducted.
The first study included 344 participants: 103 with TMD,
66 with TMD+WBP, and 175 healthy controls. The sec-
ond study included 78 participants: 33 with VBD, 23 with
VBD+IBS, and 22 healthy controls. Both cohorts included
assessments of experimental pressure and thermal heat
pain (measured using an algometer and Peltier device,
respectively), self-reported health and psychological phe-
notypes (measured using standardized questionnaires),
and circulating cytokine protein levels (measured using a
multiplex assay). The VBD cohort also included assess-
ments of intracellular microRNAs (measured using
OpenArray), which are small noncoding pieces of RNA
that control gene expression.
Results
Compared to individuals with localized pain and healthy
controls, those with TMD+WBP or VBD+IBS reported
decreased general and physical health; increased somatiza-
tion; increased interference of pain on daily activities; and
increased remote bodily pain. All cases demonstrated
increased circulating levels of the pro-inflammatory cyto-
kine interleukin-8. However those with TMD or VBD
demonstrated a compensatory increase in the anti-inflam-
matory cytokine interleukin-1 receptor antagonist, while
those with TMD+WBP or VBD+IBS did not. Individuals
with VBD displayed dysregulation of 10 microRNAs that
cumulatively regulate pathways vital for pain processing
and estrogen signaling. Those with VBD+IBS displayed
dysregulation of 11 microRNAs important for pain proces-
sing, cellular physiology, and insulin signaling. Finally,
cytokine and microRNA expression profiles were corre-
lated with pain-relevant intermediate phenotypes.
Conclusions
Individuals with localized and co-occurring pain condi-
tions differ with respect to clinical characteristics and
molecular profiles, suggesting unique underlying patholo-
gies that contribute to each subtype irrespective of the
specific anatomic site(s) involved. Cytokines and micro-
RNAs may represent valuable tools for differentiating
between these subtypes.
Acknowledgements
This work was funded by the NIH R24 DK067674, R01 NS072205P01, and
NS045685.
Center for Pain Research and Innovation, University of North Carolina,
Chapel Hill, NC 27599-7455, USA
Nackley Molecular Pain 2014, 10(Suppl 1):O11
http://www.molecularpain.com/content/10/S1/O11 MOLECULAR PAIN
© 2014 Nackley; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://
creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Published: 15 December 2014
doi:10.1186/1744-8069-10-S1-O11
Cite this article as: Nackley: Molecular correlates of localized versus co-
occurring chronic pain conditions. Molecular Pain 2014 10(Suppl 1):O11.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Nackley Molecular Pain 2014, 10(Suppl 1):O11
http://www.molecularpain.com/content/10/S1/O11
Page 2 of 2
